This looks genuinely useful. Getting more statistical power out of clinical trials, for free, means they can use smaller sample sizes and save millions. Lower e

This looks genuinely useful. Getting more statistical power out of clinical trials, for free, means they can use smaller sample sizes and save millions. Lower entry barriers means more drug trials. Not sure what the author finds "repulsive" in this.